# ACETYLCYSTEINE
> **ANDA213693** · Abbreviated New Drug Application (Generic) · Sponsor: GLENMARK PHARMS · Approved 2022-02-03
## Drug
- **FDA Application Number:** ANDA213693
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** ACETYLCYSTEINE
- **Generic name:** ACETYLCYSTEINE
- **Active ingredients:** ACETYLCYSTEINE
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** GLENMARK PHARMS
- **Manufacturer:** Glenmark Pharmaceuticals Inc., USA
- **First approval:** 2022-02-03
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213693)
---
*MORVS · CC0 1.0*